ALNY Maintained by Wells Fargo -- Price Target Lowered to $253

gurufocus.com · 2026-10-14

Alnylam Pharmaceuticals: Analyst Ratings and Valuation Insights On October 14, 2026, Wells Fargo analyst Derek Archila maintained an "Equal-Weight" rating on

Read the full story at gurufocus.com →